Fox Jonathan C 4
4 · Edgewise Therapeutics, Inc. · Filed Mar 7, 2023
Insider Transaction Report
Form 4
Fox Jonathan C
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-03-03+43,731→ 43,731 totalExercise: $9.43Exp: 2033-03-03→ Common Stock (43,731 underlying)
Footnotes (1)
- [F1]1/36th of the shares subject to the option vest each month beginning on March 3, 2023, subject to the Reporting Person continuing as a service provider through each vest date.